Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Pediatric Cardiology
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1493698
This article is part of the Research Topic Management of Congenital Heart Disease: Challenges, Implications, Innovations and Pitfalls View all 6 articles

Application-based remote interstage home monitoring for infants with shunt-or ductdependent pulmonary perfusion

Provisionally accepted
Lisa-Maria Rosenthal Lisa-Maria Rosenthal 1*Friederike Danne Friederike Danne 1Sophie De Belsunce Sophie De Belsunce 1Lisa Spath Lisa Spath 1Chiara-Aiyleen Badur Chiara-Aiyleen Badur 1Joachim Photiadis Joachim Photiadis 2Felix Berger Felix Berger 1Katharina Schmitt Katharina Schmitt 1
  • 1 Department of Congenital Heart Disease - Pediatric Cardiology, German Heart Center Berlin, Berlin, Germany
  • 2 Department of Congenital Heart Surgery, German Heart Center Berlin, Berlin, Germany

The final, formatted version of the article will be published soon.

    Objective: Interstage home-monitoring (IHM) programs are considered standard of care after Norwood palliation and have led to substantial improvements of clinical outcomes. This study aims to evaluate an application-based remote IHM program for infants with shunt- or duct-dependent pulmonary circulation. The primary goals were to discharge infants from the hospital while minimizing mortality, optimizing somatic growth, and enhance caregivers' confidence in the clinical management at home. Methods: Infants with shunt-dependent single ventricle physiology or complex biventricular physiology requiring staged palliation with aortopulmonary shunt were enrolled for the study. Caregivers completed a comprehensive education program on the clinical management of their child at home and were asked to remotely send monitoring data using an application. We analyzed demographic data, clinical outcomes and evaluated patient acceptance and adherence, as well as data entry patterns and metrics. Results were compared to a historical control group monitored in a non-remote IHM program and with a propensity score-matched cohort adjusted for baseline characteristics. Results: We enrolled 30 infants in the remote IHM program between July 2021 and May 2024. The median duration of IHM was 110 days (IQR 75-140). A median of 353 (IQR 351-743) data entries were sent per patient during IHM of which 0.8 % (IQR 0.3-1.9) were pathological. Readmissions (63 %) and interventions (57 %) were common, mainly due to cyanosis and infections. As all infants survived to stage II palliation, interstage mortality could be reduced to 0% compared to 10.3 % in the historical control group and was significantly lower compared to the propensity score-matched cohort with 14 % (p=0.032). Conclusion: Application-based remote IHM for infants with duct- or shunt dependent pulmonary perfusion is feasible, with high acceptance and adherence. The program significantly reduced interstage mortality compared to traditional monitoring methods. Remote patient monitoring (RPM) improves communication between caregivers and healthcare teams, allowing for early intervention and optimized patient outcomes. RPM has the potential to improve outcomes, enhance patient safety, and reduce family burden in this high-risk population.

    Keywords: Remote patient monitoring, interstage monitoring, application-based monitoring, Single Ventricle Heart Disease, Norwood palliation, shunt-dependent pulmonary perfusion, duct-dependent pulmonary perfusion

    Received: 09 Sep 2024; Accepted: 29 Nov 2024.

    Copyright: © 2024 Rosenthal, Danne, De Belsunce, Spath, Badur, Photiadis, Berger and Schmitt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Lisa-Maria Rosenthal, Department of Congenital Heart Disease - Pediatric Cardiology, German Heart Center Berlin, Berlin, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.